NEWS

November 2022 - Research Paper - EMERG members publish paper on HPV

EMERG members have collaborated in HP|V research and the following paper has now been published -
Autoimmunity in patients reporting long-term complications after exposure to human papilloma virus vaccination

Several EMERG researchers were involved in this paper - including EMERG co-chair Dr Jesper Mehlsen.

October 2022 - Research Paper EMERG members publish paper from #BRMEC10

EMERG member Anders Rosén was a participant in the recently published paper -
Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome
Background:
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic disease considered to be triggered by viral infections in a majority of cases. Symptoms overlap largely with those of post-acute sequelae of COVID-19/long-COVID implying common pathogenetic mechanisms. SARS-CoV-2 infection is risk factor for sustained latent virus reactivation that may account for the symptoms of post-viral fatigue syndromes. The aim of this study was first to investigate whether patients with ME/CFS and healthy donors (HDs) differed in their antibody response to mild/asymptomatic SARS-CoV-2 infection. Secondly, to analyze whether COVID-19 imposes latent virus reactivation in the cohorts.

October 2022 - EMERG members publish paper from #BRMEC10

In June 2021 at UK charity Invest in ME Research's tenth annual International Biomedical Research into ME Colloquium (#BRMEC10) ME researchers from around the world met up to discuss research, both past and current, The agenda was created with the help of The European ME Research Group and was developed to test popular hypotheses that explain the aetiology of ME.
These included: immunogenetics and dysfunctional immune responses; an abnormal autonomous nervous system and autoimmunity; mitochondrial metabolic dysfunction; and altered host-microbe (commensal and pathogen) interactions.
A paper has been published that summarises discussions in one of the hypotheses from one of the Colloquium sessions - that immune dysfunction and viral factors may drive the development and progression of ME.

April 2022 - EMERG member wins new grant for research

EMERG member Hanna Ollila has been granted an award from the Academy of Finland for research into ME.
This was one of 22 new Academy Research Fellows selected in biosciences, health and environmental research.
The selections emphasised the high scientific quality of the projects and international research cooperation.

August 2021 - A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Researchers in Bergen suggest that ME can be linked to a failure in the energy supply to the cells. They compared blood samples from patients with ME and a control group.
Researchers at the University of Bergen and Haukeland University Hospital, among others, have found differences in blood samples from ME patients and healthy people.

June 2021 - Therapies against endogenous retroviruses and their relationship with persistent covid, among the advances of the Gene Expression and Immunity Group

EMERG member from Spain, Professor Elisa Oltra, presented at the #BRMEC10 Colloquium recently. The Gene Expression and Immunity research group of the Faculty of Medicine and Health Sciences of the Catholic University of Valencia (UCV), where Elisa is the principal investigator, recently discussed her work and that of UCV research group member Karen Giménez.

June 2021 - New members of EMERG

EMERG has added new members to the team - from Norway, Serbia and Germany.

June 2020 - Netherlands to Fund Biomedical Research

A proposed research agenda has been submitted to the Dutch Minister of Health and includes research funding of € 20-29½ million over 10 years for a biomedical research program.

June 2020 - EMEA Funds EMERG Researchers

New initiative to Support the Work of European ME Research Group Researchers